Total Payments
$690,780
2024 Payments
$59,100
Companies
36
Transactions
1,052
Medicare Patients
963
Medicare Billing
$460,505
Payment Breakdown by Category
Other$501,568 (72.6%)
Consulting$139,513 (20.2%)
Travel$27,097 (3.9%)
Food & Beverage$21,409 (3.1%)
Education$1,192 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $497,818 | 185 | 72.1% |
| Consulting Fee | $139,513 | 40 | 20.2% |
| Travel and Lodging | $27,097 | 128 | 3.9% |
| Food and Beverage | $21,409 | 680 | 3.1% |
| Grant | $2,000 | 1 | 0.3% |
| Honoraria | $1,750 | 1 | 0.3% |
| Education | $1,192 | 17 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $201,988 | 183 | $0 (2024) |
| GENZYME CORPORATION | $161,483 | 168 | $0 (2024) |
| EMD Serono, Inc. | $115,599 | 151 | $0 (2024) |
| Genentech USA, Inc. | $107,168 | 92 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $44,520 | 122 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $19,125 | 43 | $0 (2022) |
| Celgene Corporation | $16,818 | 54 | $0 (2023) |
| F. Hoffmann-La Roche AG | $9,912 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $6,210 | 8 | $0 (2024) |
| ABBVIE INC. | $2,697 | 146 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59,100 | 89 | EMD Serono, Inc. ($20,920) |
| 2023 | $73,641 | 141 | EMD Serono, Inc. ($29,753) |
| 2022 | $89,931 | 138 | Biogen, Inc. ($45,484) |
| 2021 | $61,546 | 111 | GENZYME CORPORATION ($22,170) |
| 2020 | $62,953 | 91 | Biogen, Inc. ($29,981) |
| 2019 | $109,817 | 177 | Biogen, Inc. ($41,199) |
| 2018 | $115,257 | 145 | Genentech USA, Inc. ($25,857) |
| 2017 | $118,535 | 160 | GENZYME CORPORATION ($50,139) |
All Payment Transactions
1,052 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $148.69 | General |
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,055.00 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,520.00 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | Cash or cash equivalent | $186.26 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Neurology | ||||||
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,175.00 | General |
| Category: Neurology | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,110.00 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Biogen, Inc. | TYSABRI (Biological) | Travel and Lodging | Cash or cash equivalent | $65.00 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,425.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Biogen, Inc. | TYSABRI (Biological) | Travel and Lodging | Cash or cash equivalent | $31.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $61.64 | General |
| Category: Neurology | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,055.00 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 247 | 21,941 | $302,493 | $135,978 |
| 2022 | 6 | 263 | 22,260 | $305,448 | $136,774 |
| 2021 | 6 | 233 | 17,077 | $242,177 | $111,521 |
| 2020 | 6 | 220 | 11,016 | $180,627 | $76,233 |
Total Patients
963
Total Services
72,294
Medicare Billing
$460,505
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 31 | 21,600 | $216,000 | $103,670 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 233 | $53,966 | $20,663 | 38.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 24 | 67 | $21,842 | $7,615 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 23 | $7,505 | $2,799 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $3,180 | $1,230 | 38.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 29 | 21,900 | $217,002 | $101,558 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 210 | $44,778 | $18,271 | 40.8% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 24 | 69 | $21,015 | $8,195 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 30 | $8,874 | $3,501 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $9,195 | $3,279 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 30 | $4,584 | $1,970 | 43.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 26 | 16,745 | $167,450 | $81,207 | 48.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 209 | $43,890 | $17,455 | 39.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 43 | $12,169 | $5,374 | 44.2% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Office | 2021 | 18 | 48 | $13,200 | $5,157 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 20 | $2,840 | $1,291 | 45.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 12 | $2,628 | $1,037 | 39.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 18 | 10,700 | $107,000 | $51,843 | 48.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 139 | 219 | $45,990 | $14,549 | 31.6% |
| 64642 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Office | 2020 | 13 | 36 | $9,900 | $4,089 | 41.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 35 | $9,905 | $3,108 | 31.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $5,642 | $1,843 | 32.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 12 | 12 | $2,190 | $800.80 | 36.6% |
About Dr. Angela Applebee, M.D
Dr. Angela Applebee, M.D is a Neurology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508051517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Applebee, M.D has received a total of $690,780 in payments from pharmaceutical and medical device companies, with $59,100 received in 2024. These payments were reported across 1,052 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($497,818).
As a Medicare-enrolled provider, Applebee has provided services to 963 Medicare beneficiaries, totaling 72,294 services with total Medicare billing of $460,505. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Albany, NY
- Active Since 09/12/2007
- Last Updated 05/05/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1508051517
Products in Payments
- AUBAGIO (Drug) $118,078
- OCREVUS (Biological) $81,702
- TYSABRI (Biological) $67,485
- Mavenclad (Drug) $40,759
- VUMERITY (Drug) $35,047
- GILENYA (Drug) $34,668
- Ocrevus (Biological) $25,283
- LEMTRADA (Drug) $22,752
- Rebif (Biological) $20,982
- COPAXONE (Drug) $18,475
- MAVENCLAD (Drug) $18,126
- TECFIDERA (Drug) $11,265
- Non-Covered Product (Drug) $10,296
- Mavenclad (Biological) $8,914
- Ozanimod (Drug) $7,551
- ZEPOSIA (Drug) $6,032
- Tysabri (Biological) $3,678
- DISEASE STATE (Drug) $2,546
- MS DISEASE STATE (Drug) $2,110
- UPLIZNA (Drug) $1,789
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Albany
Charles Argoff, Md, MD
Neurology — Payments: $1.6M
Neurology $1.6M
Dr. Krupa Pandey, M.d, M.D
Neurology — Payments: $611,544
Neurology $611,544
Dr. Stanley Penc, Md Phd, MD PHD
Neurology — Payments: $552,076
Neurology $552,076
Dr. Timothy Lynch, Md, MD
Neurology — Payments: $273,946
Neurology $273,946
Dr. Jennifer Durphy, M.d, M.D
Neurology — Payments: $117,071
Neurology $117,071
Richard Holub, Md, MD
Neurology — Payments: $113,635
Neurology $113,635